These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16189748

  • 1. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003 Oct; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 4. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [Abstract] [Full Text] [Related]

  • 5. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 6. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 7. [The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study].
    Szulc A, Galińiska B, Tarasów E, Dzienis W, Kubas B, Konarzewska B, Waszkiewicz N, Popławska R.
    Psychiatr Pol; 2010 Jun; 44(3):415-26. PubMed ID: 20672520
    [Abstract] [Full Text] [Related]

  • 8. Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.
    de Araújo Filho GM, Lin K, Lin J, Peruchi MM, Caboclo LO, Guaranha MS, Guilhoto LM, Carrete H, Yacubian EM.
    Epilepsia; 2009 May; 50(5):1201-9. PubMed ID: 19400877
    [Abstract] [Full Text] [Related]

  • 9. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
    Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.
    Turk Psikiyatri Derg; 2006 Dec 01; 17(2):85-91. PubMed ID: 16755408
    [Abstract] [Full Text] [Related]

  • 11. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 01; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

  • 12. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, Milewski R, Walecki J.
    Neurosci Lett; 2013 Jun 28; 547():37-41. PubMed ID: 23665527
    [Abstract] [Full Text] [Related]

  • 13. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep 28; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 14. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb 28; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 15. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS, Ivanovski B, Wen W, Lagopoulos J, Moss K, Sachdev P.
    Acta Psychiatr Scand Suppl; 2007 Feb 28; (434):57-66. PubMed ID: 17688464
    [Abstract] [Full Text] [Related]

  • 16. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.
    Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517
    [Abstract] [Full Text] [Related]

  • 17. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy.
    Silverstone PH, Hanstock CC, Rotzinger S.
    J Psychiatry Neurosci; 1999 May 30; 24(3):222-6. PubMed ID: 10354656
    [Abstract] [Full Text] [Related]

  • 18. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 30; 30(1):120-5. PubMed ID: 16236417
    [Abstract] [Full Text] [Related]

  • 19. Hippocampal sclerosis: MR prediction of seizure intractability.
    Briellmann RS, Mark Wellard R, Masterton RA, Abbott DF, Berkovic SF, Jackson GD.
    Epilepsia; 2007 Feb 30; 48(2):315-23. PubMed ID: 17295625
    [Abstract] [Full Text] [Related]

  • 20. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
    Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T.
    Psychiatry Res; 1995 Nov 10; 61(4):193-200. PubMed ID: 8748464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.